MäNNEDORF, SWITZERLAND--(Marketwire - November 29, 2010) -
Tecan Group AG /
Tecan announces major OEM agreement with global diagnostics company for
development and supply of a dedicated diagnostics instrument
Processed and transmitted by Thomson Reuters.
The issuer is solely responsible for the content of this announcement.
* Agreement building upon established OEM partnership between both
* Concept development and feasibility testing already successfully
* Tecan signed a ten-year supply agreement with a purchase commitment by
* Upon successful completion of development, based on Tecan's
sales potential is estimated to be more than CHF 80 millions over the
Männedorf, Switzerland, November 29, 2010 - The Tecan Group (SWISS: TECN) today announced a major OEM agreement with a global diagnostics
for the development and supply of a dedicated diagnostics instrument. Under
global agreement, Tecan will develop and supply a fully automated
a corresponding plastic consumable. The agreement is building on an
partnership between both companies.
The development agreement follows a concept development and feasibility
phase that was already successfully completed. During the development phase
Tecan will pre-finance and capitalize the development costs of the next
generation instrument. The first half of the development costs will be
the diagnostic company upon launch of the instrument and the remaining half
year after launch. In addition to the development agreement both companies
signed a ten-year supply agreement with a purchase commitment by the
company. Upon successful completion of development, based on Tecan's
expectations the sales potential is estimated to be more than CHF 80
over the first five years. Tecan expects to ship first instruments for the
commercial launch to the diagnostics company in late 2012.
Thomas Bachmann, CEO of Tecan, said: "We are proud to have signed this
agreement with one of our existing OEM partners to develop the next
dedicated instrument. For Tecan this OEM agreement significantly broadens
market opportunity as the instrument will be marketed globally and will
penetrate new markets."
Tecan (www.tecan.com) is a leading global provider of laboratory
solutions in biopharmaceuticals, forensics, and clinical diagnostics. The
company specializes in the development, production and distribution of
instruments and automated workflow solutions for laboratories in the life
sciences sector. Its clients include pharmaceutical and biotechnology
university research departments, forensic and diagnostic laboratories. As
original equipment manufacturer, Tecan is also a leader in developing and
manufacturing OEM instruments and components that are then distributed by
partner companies. Founded in Switzerland in 1980, the company has
manufacturing, research and development sites in both Europe and North
and maintains a sales and service network in 52 countries. In 2009, Tecan
generated sales of CHF 392 million (USD 361.2 million; EUR 259.6 million).
Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK:
TECN/Reuters: TECZn.S/ ISIN CH0012100191).
--- End of Message ---
Tecan Group AG
Seestrasse 103 Männedorf Switzerland
Press Release (PDF):
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Tecan Group AG via Thomson Reuters ONE